ReP USP - Resultado da busca

Artigo de periodico
Analysis of patient-physician discrepancy in global assessment of systemic autoimmune myopathy disease activity (2022)
Cordeiro, R. A; Fischer, F. M; Shinjo, Samuel Katsuyuki
Source: Clinical and experimental rheumatology. Unidade: FM
Subjects: DERMATOPATIAS, DOENÇAS AUTOIMUNES, MIOSITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORDEIRO, R. A e FISCHER, F. M e SHINJO, Samuel Katsuyuki. Analysis of patient-physician discrepancy in global assessment of systemic autoimmune myopathy disease activity. Clinical and experimental rheumatology, v. 40, n. 2, p. 339-345, 2022Tradução . . Disponível em: https://doi.org/10.55563/CLINEXPRHEUMATOL/KEIEDV. Acesso em: 10 jun. 2024.
APA
Cordeiro, R. A., Fischer, F. M., & Shinjo, S. K. (2022). Analysis of patient-physician discrepancy in global assessment of systemic autoimmune myopathy disease activity. Clinical and experimental rheumatology, 40( 2), 339-345. doi:10.55563/CLINEXPRHEUMATOL/KEIEDV
NLM
Cordeiro RA, Fischer FM, Shinjo SK. Analysis of patient-physician discrepancy in global assessment of systemic autoimmune myopathy disease activity [Internet]. Clinical and experimental rheumatology. 2022 ; 40( 2): 339-345.[citado 2024 jun. 10 ] Available from: https://doi.org/10.55563/CLINEXPRHEUMATOL/KEIEDV
Vancouver
Cordeiro RA, Fischer FM, Shinjo SK. Analysis of patient-physician discrepancy in global assessment of systemic autoimmune myopathy disease activity [Internet]. Clinical and experimental rheumatology. 2022 ; 40( 2): 339-345.[citado 2024 jun. 10 ] Available from: https://doi.org/10.55563/CLINEXPRHEUMATOL/KEIEDV
Artigo de periodico
2019-EULAR/ACR classification criteria domains at diagnosis: predictive factors of long-term damage in systemic lupus erythematosus (2022)
Insfran, Carlos E; Aikawa, Nadia E; Pasoto, Sandra G; Filho, Dilson M. N; Formiga, Francisco F. C; Pitta, Ana C; Borba Neto, Eduardo Ferreira ; Ribeiro, Carolina T; Silva, Clovis Artur Almeida da ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Clinical rheumatology. Unidade: FM
Subjects: LÚPUS ERITEMATOSO SISTÊMICO, MULHERES 2LARPCAL, NEFROPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
INSFRAN, Carlos E et al. 2019-EULAR/ACR classification criteria domains at diagnosis: predictive factors of long-term damage in systemic lupus erythematosus. Clinical rheumatology, v. 41, n. 4, p. 1079-1085, 2022Tradução . . Disponível em: https://doi.org/10.1007/s10067-021-05989-w. Acesso em: 10 jun. 2024.
APA
Insfran, C. E., Aikawa, N. E., Pasoto, S. G., Filho, D. M. N., Formiga, F. F. C., Pitta, A. C., et al. (2022). 2019-EULAR/ACR classification criteria domains at diagnosis: predictive factors of long-term damage in systemic lupus erythematosus. Clinical rheumatology, 41( 4), 1079-1085. doi:10.1007/s10067-021-05989-w
NLM
Insfran CE, Aikawa NE, Pasoto SG, Filho DMN, Formiga FFC, Pitta AC, Borba Neto EF, Ribeiro CT, Silva CAA da, Bonfa ESD de O. 2019-EULAR/ACR classification criteria domains at diagnosis: predictive factors of long-term damage in systemic lupus erythematosus [Internet]. Clinical rheumatology. 2022 ; 41( 4): 1079-1085.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1007/s10067-021-05989-w
Vancouver
Insfran CE, Aikawa NE, Pasoto SG, Filho DMN, Formiga FFC, Pitta AC, Borba Neto EF, Ribeiro CT, Silva CAA da, Bonfa ESD de O. 2019-EULAR/ACR classification criteria domains at diagnosis: predictive factors of long-term damage in systemic lupus erythematosus [Internet]. Clinical rheumatology. 2022 ; 41( 4): 1079-1085.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1007/s10067-021-05989-w
Artigo de periodico
Increased levels of TAR DNA-binding protein 43 in the hippocampus of subjects with bipolar disorder: a postmortem study (2022)
Nascimento, Camila; Nunes, Paula Nunes; Kim, Helena K; Brentani, Helena Paula ; Jacob Filho, Wilson ; Nitrini, Ricardo ; Pasqualucci, Carlos Augusto ; Grinberg, Lea Tenenholz ; Suemoto, Claudia Kimie ; Lafer, Beny
Source: Journal of neural transmission. Unidade: FM
Subjects: TRANSTORNOS MENTAIS, TRANSTORNO BIPOLAR, NEUROIMAGEM, DEMÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASCIMENTO, Camila et al. Increased levels of TAR DNA-binding protein 43 in the hippocampus of subjects with bipolar disorder: a postmortem study. Journal of neural transmission, v. 129, n. 1, p. 95-103, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00702-021-02455-4. Acesso em: 10 jun. 2024.
APA
Nascimento, C., Nunes, P. N., Kim, H. K., Brentani, H. P., Jacob Filho, W., Nitrini, R., et al. (2022). Increased levels of TAR DNA-binding protein 43 in the hippocampus of subjects with bipolar disorder: a postmortem study. Journal of neural transmission, 129( 1), 95-103. doi:10.1007/s00702-021-02455-4
NLM
Nascimento C, Nunes PN, Kim HK, Brentani HP, Jacob Filho W, Nitrini R, Pasqualucci CA, Grinberg LT, Suemoto CK, Lafer B. Increased levels of TAR DNA-binding protein 43 in the hippocampus of subjects with bipolar disorder: a postmortem study [Internet]. Journal of neural transmission. 2022 ; 129( 1): 95-103.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1007/s00702-021-02455-4
Vancouver
Nascimento C, Nunes PN, Kim HK, Brentani HP, Jacob Filho W, Nitrini R, Pasqualucci CA, Grinberg LT, Suemoto CK, Lafer B. Increased levels of TAR DNA-binding protein 43 in the hippocampus of subjects with bipolar disorder: a postmortem study [Internet]. Journal of neural transmission. 2022 ; 129( 1): 95-103.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1007/s00702-021-02455-4
Artigo de periodico
Exacerbation of psychosis risk during the COVID-19 pandemic: the disproportionate impact on the lower income population (2022)
Loch, Alexandre Andrade; Mota, Natalia Bezerra; Roessler, Wulf; Gattaz, Wagner Farid
Source: Psychiatry research. Unidade: FM
Subjects: COVID-19, FATORES SOCIOECONÔMICOS, PSICOSE EM ADULTO, PANDEMIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOCH, Alexandre Andrade et al. Exacerbation of psychosis risk during the COVID-19 pandemic: the disproportionate impact on the lower income population. Psychiatry research, v. 307, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.psychres.2021.114319. Acesso em: 10 jun. 2024.
APA
Loch, A. A., Mota, N. B., Roessler, W., & Gattaz, W. F. (2022). Exacerbation of psychosis risk during the COVID-19 pandemic: the disproportionate impact on the lower income population. Psychiatry research, 307. doi:10.1016/j.psychres.2021.114319
NLM
Loch AA, Mota NB, Roessler W, Gattaz WF. Exacerbation of psychosis risk during the COVID-19 pandemic: the disproportionate impact on the lower income population [Internet]. Psychiatry research. 2022 ; 307[citado 2024 jun. 10 ] Available from: https://doi.org/10.1016/j.psychres.2021.114319
Vancouver
Loch AA, Mota NB, Roessler W, Gattaz WF. Exacerbation of psychosis risk during the COVID-19 pandemic: the disproportionate impact on the lower income population [Internet]. Psychiatry research. 2022 ; 307[citado 2024 jun. 10 ] Available from: https://doi.org/10.1016/j.psychres.2021.114319
Artigo de periodico
Neuropsychiatric symptoms and cerebrovascular risk in non-demented elders: cross-sectional study using the mild behavioural impairment checklist (MBI-C) (2022)
Stella, Florindo; Pais, Marcos V; Loureiro, Julia C; Radanovic, Marcia; Forlenza, Orestes Vicente
Source: Psychogeriatrics. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, SINAIS E SINTOMAS, NEUROIMAGEM, DIAGNÓSTICO POR IMAGEM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STELLA, Florindo et al. Neuropsychiatric symptoms and cerebrovascular risk in non-demented elders: cross-sectional study using the mild behavioural impairment checklist (MBI-C). Psychogeriatrics, v. 22, n. 1, p. 55-66, 2022Tradução . . Disponível em: https://doi.org/10.1111/psyg.12776. Acesso em: 10 jun. 2024.
APA
Stella, F., Pais, M. V., Loureiro, J. C., Radanovic, M., & Forlenza, O. V. (2022). Neuropsychiatric symptoms and cerebrovascular risk in non-demented elders: cross-sectional study using the mild behavioural impairment checklist (MBI-C). Psychogeriatrics, 22( 1), 55-66. doi:10.1111/psyg.12776
NLM
Stella F, Pais MV, Loureiro JC, Radanovic M, Forlenza OV. Neuropsychiatric symptoms and cerebrovascular risk in non-demented elders: cross-sectional study using the mild behavioural impairment checklist (MBI-C) [Internet]. Psychogeriatrics. 2022 ; 22( 1): 55-66.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1111/psyg.12776
Vancouver
Stella F, Pais MV, Loureiro JC, Radanovic M, Forlenza OV. Neuropsychiatric symptoms and cerebrovascular risk in non-demented elders: cross-sectional study using the mild behavioural impairment checklist (MBI-C) [Internet]. Psychogeriatrics. 2022 ; 22( 1): 55-66.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1111/psyg.12776
Artigo de periodico
Serum myostatin and follistatin levels in patients with dermatomyositis and polymyositis (2022)
Sordi, Cintia M. de; Reis-Neto, Edgard T. dos; Keppeke, Gerson D; Shinjo, Samuel Katsuyuki ; Sato, Emilia Inoue
Source: Jcr-journal of clinical rheumatology. Unidade: FM
Subjects: DERMATOPATIAS, MIOSITE, MUTAÇÃO GENÉTICA, RATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SORDI, Cintia M. de et al. Serum myostatin and follistatin levels in patients with dermatomyositis and polymyositis. Jcr-journal of clinical rheumatology, v. 28, n. 1, p. 33-37, 2022Tradução . . Disponível em: https://doi.org/10.1097/RHU.0000000000001806. Acesso em: 10 jun. 2024.
APA
Sordi, C. M. de, Reis-Neto, E. T. dos, Keppeke, G. D., Shinjo, S. K., & Sato, E. I. (2022). Serum myostatin and follistatin levels in patients with dermatomyositis and polymyositis. Jcr-journal of clinical rheumatology, 28( 1), 33-37. doi:10.1097/RHU.0000000000001806
NLM
Sordi CM de, Reis-Neto ET dos, Keppeke GD, Shinjo SK, Sato EI. Serum myostatin and follistatin levels in patients with dermatomyositis and polymyositis [Internet]. Jcr-journal of clinical rheumatology. 2022 ; 28( 1): 33-37.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1097/RHU.0000000000001806
Vancouver
Sordi CM de, Reis-Neto ET dos, Keppeke GD, Shinjo SK, Sato EI. Serum myostatin and follistatin levels in patients with dermatomyositis and polymyositis [Internet]. Jcr-journal of clinical rheumatology. 2022 ; 28( 1): 33-37.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1097/RHU.0000000000001806
Artigo de periodico
Sphingolipids signature in plasma and tissue as diagnostic and prognostic tools in oral squamous cell carcinoma (2022)
Faedo, Raquel Roman; Silva, Gabriel da ; Silva, Rodrigo Moreira da ; Ushida, Tatiane Resende; Silva, Ricardo Roberto da ; Lacchini, Riccardo ; Matos, Leandro Luongo de; Kowalski, Luiz Paulo ; Lopes, Norberto Peporine ; Leopoldino, Andréia Machado
Source: Biochimica et biophysica acta-molecular and cell biology of lipids. Unidades: FM, FCFRP, EERP
Subjects: NEOPLASIAS BUCAIS, PLASMA, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAEDO, Raquel Roman et al. Sphingolipids signature in plasma and tissue as diagnostic and prognostic tools in oral squamous cell carcinoma. Biochimica et biophysica acta-molecular and cell biology of lipids, v. 1867, n. 1, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.bbalip.2021.159057. Acesso em: 10 jun. 2024.
APA
Faedo, R. R., Silva, G. da, Silva, R. M. da, Ushida, T. R., Silva, R. R. da, Lacchini, R., et al. (2022). Sphingolipids signature in plasma and tissue as diagnostic and prognostic tools in oral squamous cell carcinoma. Biochimica et biophysica acta-molecular and cell biology of lipids, 1867( 1). doi:10.1016/j.bbalip.2021.159057
NLM
Faedo RR, Silva G da, Silva RM da, Ushida TR, Silva RR da, Lacchini R, Matos LL de, Kowalski LP, Lopes NP, Leopoldino AM. Sphingolipids signature in plasma and tissue as diagnostic and prognostic tools in oral squamous cell carcinoma [Internet]. Biochimica et biophysica acta-molecular and cell biology of lipids. 2022 ; 1867( 1):[citado 2024 jun. 10 ] Available from: https://doi.org/10.1016/j.bbalip.2021.159057
Vancouver
Faedo RR, Silva G da, Silva RM da, Ushida TR, Silva RR da, Lacchini R, Matos LL de, Kowalski LP, Lopes NP, Leopoldino AM. Sphingolipids signature in plasma and tissue as diagnostic and prognostic tools in oral squamous cell carcinoma [Internet]. Biochimica et biophysica acta-molecular and cell biology of lipids. 2022 ; 1867( 1):[citado 2024 jun. 10 ] Available from: https://doi.org/10.1016/j.bbalip.2021.159057
Artigo de periodico
Lithium modulates multiple tau kinases with distinct effects in cortical and hippocampal neurons according to concentration ranges (2022)
De-Paula, V. J.; Forlenza, Orestes Vicente
Source: Naunyn-schmiedebergs archives of pharmacology. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, LÍTIO, NEURÔNIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DE-PAULA, V. J. e FORLENZA, Orestes Vicente. Lithium modulates multiple tau kinases with distinct effects in cortical and hippocampal neurons according to concentration ranges. Naunyn-schmiedebergs archives of pharmacology, v. 395, n. 1, p. 105-113, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00210-021-02171-6. Acesso em: 10 jun. 2024.
APA
De-Paula, V. J., & Forlenza, O. V. (2022). Lithium modulates multiple tau kinases with distinct effects in cortical and hippocampal neurons according to concentration ranges. Naunyn-schmiedebergs archives of pharmacology, 395( 1), 105-113. doi:10.1007/s00210-021-02171-6
NLM
De-Paula VJ, Forlenza OV. Lithium modulates multiple tau kinases with distinct effects in cortical and hippocampal neurons according to concentration ranges [Internet]. Naunyn-schmiedebergs archives of pharmacology. 2022 ; 395( 1): 105-113.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1007/s00210-021-02171-6
Vancouver
De-Paula VJ, Forlenza OV. Lithium modulates multiple tau kinases with distinct effects in cortical and hippocampal neurons according to concentration ranges [Internet]. Naunyn-schmiedebergs archives of pharmacology. 2022 ; 395( 1): 105-113.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1007/s00210-021-02171-6
Artigo de periodico
Assessing undertreatment and overtreatment/misuse of ADHD medications in children and adolescents across continents: a systematic review and meta-analysis (2021)
Massuti, Rafael; Moreira-Maia, Carlos Renato; Campani, Fausto; Sonego, Marcio; Amaro, Julia; Akutagava-martins, Glaucia Chiyoko; Tessari, Luca; Polanczyk, Guilherme Vanoni ; Cortese, Samuele; Rohde, Luis Augusto
Source: Neuroscience and biobehavioral reviews. Unidade: FM
Subjects: DEFICIT, HIPERATIVIDADE, ESTUDANTES DE ENSINO FUNDAMENTAL, CRIANÇAS, PREVALÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MASSUTI, Rafael et al. Assessing undertreatment and overtreatment/misuse of ADHD medications in children and adolescents across continents: a systematic review and meta-analysis. Neuroscience and biobehavioral reviews, v. 128, p. 64-73, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.neubiorev.2021.06.001. Acesso em: 10 jun. 2024.
APA
Massuti, R., Moreira-Maia, C. R., Campani, F., Sonego, M., Amaro, J., Akutagava-martins, G. C., et al. (2021). Assessing undertreatment and overtreatment/misuse of ADHD medications in children and adolescents across continents: a systematic review and meta-analysis. Neuroscience and biobehavioral reviews, 128, 64-73. doi:10.1016/j.neubiorev.2021.06.001
NLM
Massuti R, Moreira-Maia CR, Campani F, Sonego M, Amaro J, Akutagava-martins GC, Tessari L, Polanczyk GV, Cortese S, Rohde LA. Assessing undertreatment and overtreatment/misuse of ADHD medications in children and adolescents across continents: a systematic review and meta-analysis [Internet]. Neuroscience and biobehavioral reviews. 2021 ; 128 64-73.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1016/j.neubiorev.2021.06.001
Vancouver
Massuti R, Moreira-Maia CR, Campani F, Sonego M, Amaro J, Akutagava-martins GC, Tessari L, Polanczyk GV, Cortese S, Rohde LA. Assessing undertreatment and overtreatment/misuse of ADHD medications in children and adolescents across continents: a systematic review and meta-analysis [Internet]. Neuroscience and biobehavioral reviews. 2021 ; 128 64-73.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1016/j.neubiorev.2021.06.001

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Source title

Countries/Territories

Funding Agencies